AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35583870 — intervention group
Group type: COMPARATOR
Intervention: AC
Number of subjects: 271
Study 33074950 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Exchange (WE)
Number of subjects: 262
Study 33074950 — intervention group
Group type: COMPARATOR
Intervention: Carbon Dioxide (CO2)
Number of subjects: 262
Study 32537740 — intervention group
Group type: EXPERIMENTAL
Intervention: Utilization of the ECG Belt to guide implant as well as postimplant programming
Number of subjects: 400
Study 32537740 — intervention group
Group type: EXPERIMENTAL
Intervention: Utilizing the ECG Belt to guide postimplant programming alone
Number of subjects: 400
Study 32537740 — intervention group
Group type: COMPARATOR
Intervention: Non-Belt control arm
Number of subjects: 400
Study 36226977 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib 15 mg
Number of subjects: 211
Study 36226977 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib 5 mg
Number of subjects: 211
Study 36226977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211
Study 32684099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame Oil (SO)
Number of subjects: 77
Study 32684099 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola Oil (CO)
Number of subjects: 77
Study 32684099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame-Canola Oil (SCO)
Number of subjects: 77
Study 32684099 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 77
Study 33112254 — intervention group
Group type: EXPERIMENTAL
Intervention: Competent Adulthood Transition with Cognitive Behavioral Humanistic and Interpersonal Training
Number of subjects: 369
Study 33112254 — intervention group
Group type: COMPARATOR
Intervention: Health education (active control)
Number of subjects: 369
Study 33812736 — intervention group
Group type: EXPERIMENTAL
Intervention: High Mediterranean Diet Scores (MDS)
Number of subjects: 50
Study 33812736 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Mediterranean Diet Scores (MDS)
Number of subjects: 50
Study 33812736 — intervention group
Group type: COMPARATOR
Intervention: Stage 1-2 CKD
Number of subjects: 50
Study 33812736 — intervention group
Group type: COMPARATOR
Intervention: Hyperkalemia
Number of subjects: 50
Study 32134931 — intervention group
Group type: EXPERIMENTAL
Intervention: DMPA-IM
Number of subjects: 54
Study 32134931 — intervention group
Group type: COMPARATOR
Intervention: non-HC
Number of subjects: 54
Study 35967517 — intervention group
Group type: EXPERIMENTAL
Intervention: Naldemedine
Number of subjects: 0
Study 35967517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32017867 — intervention group
Group type: EXPERIMENTAL
Intervention: Raise Your Resilience group intervention
Number of subjects: 89
Study 32017867 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 89
Study 33809796 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium meal plan (<0.95 mg/kcal)
Number of subjects: 20
Study 33809796 — intervention group
Group type: COMPARATOR
Intervention: Typical sodium meal plan (>2 mg/kcal)
Number of subjects: 20
Study 33809796 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium meal plan
Number of subjects: 20
Study 32406601 — intervention group
Group type: EXPERIMENTAL
Intervention: Colesevelam 3.75 g daily
Number of subjects: 200
Study 32406601 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe 10 mg daily
Number of subjects: 200
Study 35012771 — intervention group
Group type: EXPERIMENTAL
Intervention: tEPA
Number of subjects: 151
Study 35012771 — intervention group
Group type: COMPARATOR
Intervention: BMG
Number of subjects: 151
Study 34468979 — intervention group
Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin
Number of subjects: 0
Study 32427555 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth ultrasonic supra- and subgingival debridement + Er,Cr:YSGG laser application
Number of subjects: 59
Study 32427555 — intervention group
Group type: COMPARATOR
Intervention: Full-mouth ultrasonic supra- and subgingival debridement + root planing with Gracey curettes
Number of subjects: 59
Study 37027137 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual sleep efficiency of 75% to 84%
Number of subjects: 498
Study 37027137 — intervention group
Group type: EXPERIMENTAL
Intervention: Taking sleep medications once or twice a week
Number of subjects: 498
Study 37027137 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of daytime dysfunction less than once a week
Number of subjects: 498
Study 37027137 — intervention group
Group type: EXPERIMENTAL
Intervention: Taking sleep medications less than once a week
Number of subjects: 498
Study 32845061 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning XGBoost model
Number of subjects: 19331
Study 32845061 — intervention group
Group type: COMPARATOR
Intervention: Traditional logistic model
Number of subjects: 19331
Study 32460882 — intervention group
Group type: EXPERIMENTAL
Intervention: Distribution-based methods
Number of subjects: 393
Study 32460882 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 SD and 1/3 SD distribution methods
Number of subjects: 393
Study 32460882 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple imputation by mean score
Number of subjects: 393
Study 32460882 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple imputations techniques
Number of subjects: 393
Study 32460882 — intervention group
Group type: EXPERIMENTAL
Intervention: Using 3 measurement occasions
Number of subjects: 393
Study 36229579 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat sequential two FLOX cycles and two immune checkpoint blockade (ICB) cycles
Number of subjects: 66
Study 36229579 — intervention group
Group type: COMPARATOR
Intervention: Control arm (oxaliplatin‐based Nordic FLOX regimen)
Number of subjects: 66
Study 33200649 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous inner forearm cooling (COOL)
Number of subjects: 11
Study 33200649 — intervention group
Group type: COMPARATOR
Intervention: No cooling (CONTROL)
Number of subjects: 11
Study 32365607 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Treatment (IT)
Number of subjects: 30
Study 32365607 — intervention group
Group type: COMPARATOR
Intervention: Delayed Treatment Control (DTC)
Number of subjects: 30
Study 35841234 — intervention group
Group type: EXPERIMENTAL
Intervention: Soticlestat (≤300 mg twice daily, weight-adjusted)
Number of subjects: 141
Study 35841234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 34090216 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil-based intravenous lipid emulsion (OO-based IVLE)
Number of subjects: 210
Study 34090216 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil-based intravenous lipid emulsion (SO-based IVLE)
Number of subjects: 210
Study 34090216 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (OO and SO-based IVLE)
Number of subjects: 210
Study 33988337 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose trivalent inactivated influenza vaccination (SDTIIV)
Number of subjects: 176
Study 33988337 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-dose trivalent inactivated influenza vaccination (DDTIIV)
Number of subjects: 176
Study 33988337 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster-dose trivalent inactivated influenza vaccination (BDTIIV)
Number of subjects: 176
Study 32930794 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-offset community-supported agriculture (CO-CSA) with a 50% subsidized share of local produce and nine complimentary nutrition classes
Number of subjects: 305
Study 32815101 — intervention group
Group type: EXPERIMENTAL
Intervention: En bloc technique
Number of subjects: 50
Study 32815101 — intervention group
Group type: COMPARATOR
Intervention: Standard technique (GlideScope‐first‐then‐ETT)
Number of subjects: 50
Study 32815101 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 50
Study 36458916 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled sargramostim (125 mcg twice daily for 5 days)
Number of subjects: 122
Study 36458916 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 122
Study 32808151 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory of Mind (ToM) intervention
Number of subjects: 141
Study 32808151 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 141
Study 34940806 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-Valent Pneumococcal Conjugate Vaccine (PCV20)
Number of subjects: 1000
Study 34940806 — intervention group
Group type: COMPARATOR
Intervention: 13-Valent Pneumococcal Conjugate Vaccine (PCV13)
Number of subjects: 1000
Study 34940806 — intervention group
Group type: COMPARATOR
Intervention: 23-Valent Polysaccharide Vaccine (PPSV23)
Number of subjects: 1000
Study 32132228 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive preschool curriculum (intervention)
Number of subjects: 150
Study 32132228 — intervention group
Group type: COMPARATOR
Intervention: Basic preschool curriculum (non-intervention)
Number of subjects: 150
Study 34114608 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaf expander (moderate continuous forces)
Number of subjects: 56
Study 34114608 — intervention group
Group type: COMPARATOR
Intervention: Rapid maxillary expander (RME)
Number of subjects: 56
Study 34897453 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive video intervention (n = 50)
Number of subjects: 101
Study 34897453 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 51)
Number of subjects: 101
Study 33321405 — intervention group
Group type: EXPERIMENTAL
Intervention: Stigmatized language framing (emphasizing connection between China and COVID-19)
Number of subjects: 1451
Study 33321405 — intervention group
Group type: EXPERIMENTAL
Intervention: Emphasizing economic impact of COVID-19
Number of subjects: 1451
Study 33321405 — intervention group
Group type: COMPARATOR
Intervention: Messages emphasizing serious health risks of COVID-19
Number of subjects: 1451
Study 32737091 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 84
Study 32737091 — intervention group
Group type: COMPARATOR
Intervention: Conscious sedation
Number of subjects: 84
Study 35972855 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined islatravir groups
Number of subjects: 121
Study 33797665 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher participation in physical activity
Number of subjects: 82
Study 33797665 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Reinforcement feedback
Number of subjects: 82
Study 33797665 — intervention group
Group type: EXPERIMENTAL
Intervention: Technical Instruction feedback
Number of subjects: 82
Study 33797665 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative feedback
Number of subjects: 82
Study 33797665 — intervention group
Group type: EXPERIMENTAL
Intervention: Game Instruction
Number of subjects: 82
Study 32006650 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue photodynamic therapy (MB-PDT) applied twice a week for four weeks
Number of subjects: 20
Study 32006650 — intervention group
Group type: COMPARATOR
Intervention: Topical betamethasone valerate ointment 100 mg applied three times per day for four weeks
Number of subjects: 20
Study 36340698 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrients
Number of subjects: 150
Study 36340698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 34795753 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education
Number of subjects: 433
Study 34795753 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (nutrition and physical activity education)
Number of subjects: 433
Study 34795753 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity education
Number of subjects: 433
Study 34795753 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 433
Study 35358428 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy with artemether–lumefantrine plus amodiaquine
Number of subjects: 0
Study 35358428 — intervention group
Group type: COMPARATOR
Intervention: Artemether–lumefantrine alone
Number of subjects: 0
Study 33512796 — intervention group
Group type: EXPERIMENTAL
Intervention: L3-20 (20 Necator americanus larvae)
Number of subjects: 54
Study 33512796 — intervention group
Group type: EXPERIMENTAL
Intervention: L3-40 (40 Necator americanus larvae)
Number of subjects: 54
Study 33512796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 33512796 — intervention group
Group type: EXPERIMENTAL
Intervention: Hookworm-positive participants
Number of subjects: 54
Study 35766202 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined injection (intra and periarticular) of methylprednisolone acetate 40 mg and local anesthetic
Number of subjects: 60
Study 35766202 — intervention group
Group type: COMPARATOR
Intervention: Intraarticular injection of methylprednisolone acetate 40 mg and local anesthetic
Number of subjects: 60
Study 33624730 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg body mass)
Number of subjects: 16
Study 33624730 — intervention group
Group type: COMPARATOR
Intervention: Cellulose (placebo)
Number of subjects: 16
Study 35260100 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional plus PSMA PET imaging with intensified radiotherapy or surgery
Number of subjects: 776
Study 35260100 — intervention group
Group type: COMPARATOR
Intervention: Conventional imaging
Number of subjects: 776
Study 35260100 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional plus PSMA PET imaging
Number of subjects: 776
Study 34594197 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic massage robot (ADAMO)
Number of subjects: 44
Study 34594197 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (manual pressure release of myofascial trigger points)
Number of subjects: 44
Study 35918731 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused, expert medication management intervention including in-person consultation and virtual care follow-up.
Number of subjects: 0
Study 35918731 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus encouragement to use the Thrombosis Canada website.
Number of subjects: 0
Study 34283694 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation (PR) initiated within 90 days of discharge
Number of subjects: 19376
Study 34283694 — intervention group
Group type: COMPARATOR
Intervention: No Pulmonary Rehabilitation (Control)
Number of subjects: 19376
Study 34283694 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation (PR)
Number of subjects: 19376
Study 32700359 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol plus letrozole
Number of subjects: 120
Study 32700359 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol only
Number of subjects: 120
Study 36118690 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 213
Study 36118690 — intervention group
Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 213
Study 34311606 — intervention group
Group type: EXPERIMENTAL
Intervention: Single alcoholic beverage administration (placebo 0.00%, low 0.03%, moderate 0.06%, high 0.09%)
Number of subjects: 0
Study 34311606 — intervention group
Group type: COMPARATOR
Intervention: Cumulative alcoholic administration method (placebo followed by three alcoholic drinks)
Number of subjects: 0
Study 34001367 — intervention group
Group type: EXPERIMENTAL
Intervention: 18% CP and low RUP:RDP ratio (18CP-LR)
Number of subjects: 48
Study 34001367 — intervention group
Group type: EXPERIMENTAL
Intervention: 18% CP and high RUP:RDP ratio (18CP-HR)
Number of subjects: 48
Study 34001367 — intervention group
Group type: EXPERIMENTAL
Intervention: 22% CP and low RUP:RDP ratio (22CP-LR)
Number of subjects: 48
Study 34001367 — intervention group
Group type: EXPERIMENTAL
Intervention: 22% CP and high RUP:RDP ratio (22CP-HR)
Number of subjects: 48
Study 34001367 — intervention group
Group type: EXPERIMENTAL
Intervention: High RUP:RDP ratio (HR)
Number of subjects: 48
Study 34001367 — intervention group
Group type: EXPERIMENTAL
Intervention: 22% CP diets
Number of subjects: 48
Study 32446921 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep hypothermic circulatory arrest
Number of subjects: 45
Study 32446921 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective antegrade cerebral perfusion
Number of subjects: 45
Study 32446921 — intervention group
Group type: EXPERIMENTAL
Intervention: Double arterial cannulation
Number of subjects: 45
Study 34621458 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS‐GS‐TBCB
Number of subjects: 59
Study 34621458 — intervention group
Group type: COMPARATOR
Intervention: EBUS‐GS‐TBB
Number of subjects: 59
Study 33064404 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory training
Number of subjects: 69
Study 33064404 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming
Number of subjects: 69
Study 33064404 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 69
Study 35725538 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated interactive text message program (n = 57)
Number of subjects: 112
Study 35725538 — intervention group
Group type: COMPARATOR
Intervention: Assessment control (n = 55)
Number of subjects: 112
Study 33982320 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous mineralized dentin matrix (MDM)
Number of subjects: 52
Study 33982320 — intervention group
Group type: COMPARATOR
Intervention: Xenograft granules
Number of subjects: 52
Study 32279615 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical silicone gel plus herbal extract gel (Allium cepa, Centella Asiatica, Aloe vera and Paper Mulberry)
Number of subjects: 46
Study 32279615 — intervention group
Group type: COMPARATOR
Intervention: Silicone gel
Number of subjects: 46
Study 32829456 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) educational intervention for radiotherapy patients
Number of subjects: 60
Study 32829456 — intervention group
Group type: COMPARATOR
Intervention: Standard nursing care process (control group)
Number of subjects: 60
Study 32522282 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg x 1 for Day 1-3, 250 mg x 1 for Day 4-15) and Hydroxychloroquine (200 mg x 2 for Day 1-15)
Number of subjects: 226
Study 32522282 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment + placebo
Number of subjects: 226
Study 36045653 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching-based teleoccupational guidance (CTG)
Number of subjects: 92
Study 36045653 — intervention group
Group type: COMPARATOR
Intervention: Standard telerehabilitation
Number of subjects: 92
Study 33152309 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 0
Study 33152309 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 0
Study 32276134 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood triglyceride (TG) levels
Number of subjects: 15244
Study 32276134 — intervention group
Group type: EXPERIMENTAL
Intervention: NonHDL‐c levels
Number of subjects: 15244
Study 32276134 — intervention group
Group type: EXPERIMENTAL
Intervention: TC:HDL‐c ratio
Number of subjects: 15244
Study 32276134 — intervention group
Group type: EXPERIMENTAL
Intervention: TG:HDL‐c ratio
Number of subjects: 15244
Study 32276134 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL‐c levels
Number of subjects: 15244
Study 32276134 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predicted blood TG level increase
Number of subjects: 15244
Study 33090733 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-986166 (0.75-5.0 mg single dose and 0.25-1.5 mg/day repeated dose)
Number of subjects: 0
Study 33090733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33090733 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-986166 (0.5 mg/day)
Number of subjects: 0
Study 32080133 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printing technique
Number of subjects: 32
Study 32080133 — intervention group
Group type: COMPARATOR
Intervention: Routine surgical treatment without 3D printing
Number of subjects: 32
Study 35603798 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) with compression therapy
Number of subjects: 40
Study 35603798 — intervention group
Group type: COMPARATOR
Intervention: Placebo + compression therapy alone
Number of subjects: 40
Study 33825020 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth rinsing
Number of subjects: 5
Study 33825020 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental spray
Number of subjects: 5
Study 33825020 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste gel
Number of subjects: 5
Study 33825020 — intervention group
Group type: COMPARATOR
Intervention: Mouth rinsing and spray application
Number of subjects: 5
Study 32699128 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-feedback Intervention Group
Number of subjects: 0
Study 32699128 — intervention group
Group type: COMPARATOR
Intervention: Control Group ('dummy' intervention: telephone calls)
Number of subjects: 0
Study 35799120 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion‐Focused Skills Training (EFST)
Number of subjects: 120
Study 35799120 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 120
Study 33859411 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning framework for analyzing Cytosponge-TFF3 test samples; specific dosage and duration not mentioned.
Number of subjects: 2331
Study 32496600 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory organizational intervention (2 x 2 hr workshops over 1 year)
Number of subjects: 625
Study 32496600 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 625
Study 36002178 — intervention group
Group type: COMPARATOR
Intervention: White noise (control)
Number of subjects: 121
Study 33373631 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-only HWLs
Number of subjects: 1185
Study 33373631 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-only HWLs
Number of subjects: 1185
Study 33373631 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-and-text HWLs
Number of subjects: 1185
Study 33373631 — intervention group
Group type: COMPARATOR
Intervention: No HWLs (control)
Number of subjects: 1185
Study 32853634 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 2630